Press release
APAC Lateral Flow Diagnostic Tests Market to be worth US$3.22 bn by 2023
Transparency Market Research has identified Alere, Inc., Beckman Coulter, Inc., Becton, Bio-Rad Laboratories, F. Hoffmann-La Roche Ltd. as the key players in the Asia Pacific lateral flow diagnostic tests market. The market is consolidated in nature and thus highly competitive. To stay afloat in the cut-throat competition players are investing in developing technologically advanced lateral flow diagnostic test procedures.Download Free exclusive Sample of this report:
http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=7739
“A huge scope for improvement has created a perfect space in the APAC market for the new entrants,” says the lead author of this research report. New players will have to counter the existing competition through intense research and development activities, strategic mergers and acquisitions, and building a solid brand value to grab a sustainable share in the overall market.
Heightened Awareness of Diseases in APAC Boosts Lateral Flow Diagnostic Tests Market
A high prevalence of diseases such as cancer, cardiovascular diseases, diabetes, and other infectious diseases has increased healthcare spending, which has had a positive influence on the revenues of lateral flow diagnostic tests market. The rising disposable income and growing awareness amongst overall population to prevent infections are also providing an additional boost to this market. Furthermore, remarkable developments in the healthcare sector and the availability of improved devices and drugs are also expected to boost this market in the coming few years.
The preference of patients and physicians to utilize the near-patient diagnosis options to get instant results, reduce treatment costs, and thus cut down on the hospital stay time is also working in favor of this market. These immediate diagnostic results are crucial in delivering immediate medical assistance to avoid delay in treatment and prevent complications. All of these factors are expected to augment the APAC lateral flow diagnostic tests market in the coming years.
Inaccuracy of Results Remains Demerit of Lateral Flow Diagnostic Tests
The inaccuracy of results delivered by lateral flow diagnostic tests is the biggest challenge this market faces. Currently, the lateral flow diagnostic tests are only meant for diagnosis at home or for point-of-care testing. Furthermore, the incorrect sampling at home can also lead to poor disease management and worsen the actual diagnosis.
Pregnancy Tests Poised to Exhibit Strong Sales Growth
The report states that the opportunity in the APAC lateral flow diagnostic tests market was worth US$2.30 bn in 2015 and will reach US$3.22 bn by the end of 2023. Between the forecast period of 2015 and 2023, the overall market is expected to expand at a CAGR of 5.7%. Amongst the application segments, the pregnancy application segment held the largest share in 2014 and is expected to expand at a CAGR of 4.5% over the forecast period. The growth of this application segment will be a result of the growing female population and a rising awareness about pregnancy testing amongst them.
On the other hand, the hepatitis application segment is expected to grow at the highest CAGR of 8.3% between 2015 and 2023 due to a sudden rise in autoimmune and contagious diseases across Asia Pacific.
About Us
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who us e proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Contact
Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release APAC Lateral Flow Diagnostic Tests Market to be worth US$3.22 bn by 2023 here
News-ID: 360225 • Views: …
More Releases from TMR - Medical
Compression Therapy Market will exhibit a CAGR of 5.3% between 2016 and 2024
For the majority of sportspersons and athletes, compression therapy is one of the most common procedures of treating injuries. Over the years, the therapy has been facilitating the healing process in various cases of musculoskeletal and spinal injuries. Besides this, the increasing number of orthopedic surgeries conducted worldwide also has been fuelling demand for compression therapy. With the increasing obese population, the global compression therapy market stands to reach US$4.24…
Biomaterials Market expected to rise at a CAGR of 4.1% between 2013 and 2019
The global biomaterials market for implantable devices is currently exhibiting a highly fragmented vendor landscape. The presence of a large number of companies has triggered intense rivalry among the existing players. As an inevitable response to the prevailing competition, these companies have been engaged in extensive research and development activities. Enterprises such as AdvanSource Biomaterials Corp., Celanese Corp., Celanese Corp., Evonik Industries AG, DuPont, and others have been investing in…
More Releases for APAC
Bronchopulmonary Dysplasia APAC Market Poised for Phenomenal Expansion Across AP …
DelveInsight's "Bronchopulmonary Dysplasia- Patient Pool Analysis, Market Size and Market Forecast APAC, 2034" report comprises of detailed understanding of the Bronchopulmonary Dysplasia, historical and forecasted patient burden, treatment addressable patient population, as well as key differences in market trends in the APAC region (India, China, South Korea, Taiwan, and Australia) when compared with established markets.
The APAC Bronchopulmonary Dysplasia market report provides current treatment pattern analysis, potential upcoming players, market share…
Allergic Rhinitis APAC Market Poised for Phenomenal Expansion Across APAC Region …
"DelveInsight's "Allergic Rhinitis- Patient Pool Analysis, Market Size and Market Forecast APAC, 2034" report comprises of detailed understanding of the Allergic Rhinitis, historical and forecasted patient burden, treatment addressable patient population, as well as key differences in market trends in the APAC region (India, China, South Korea, Taiwan, and Australia) when compared with established markets.
The APAC Allergic Rhinitis market report provides current treatment pattern analysis, potential upcoming players, market share…
Epilepsy APAC Market Poised for Phenomenal Expansion Across APAC Region in the C …
DelveInsight's "Epilepsy- Patient Pool Analysis, Market Size and Market Forecast APAC, 2034" report comprises of detailed understanding of the Epilepsy, historical and forecasted patient burden, treatment addressable patient population, as well as key differences in market trends in the APAC region (India, China, South Korea, Taiwan, and Australia) when compared with established markets.
The APAC Epilepsy market report provides current treatment pattern analysis, potential upcoming players, market share of approved and…
Insomnia APAC Market Poised for Phenomenal Expansion Across APAC Region in the C …
DelveInsight's "Insomnia- Patient Pool Analysis, Market Size and Market Forecast APAC, 2034" report comprises of detailed understanding of the Insomnia, historical and forecasted patient burden, treatment addressable patient population, as well as key differences in market trends in the APAC region (India, China, South Korea, Taiwan, and Australia) when compared with established markets.
The APAC Insomnia market report provides current treatment pattern analysis, potential upcoming players, market share of approved and…
Vascular Dementia APAC Market Poised for Phenomenal Expansion Across APAC Region …
DelveInsight's "Vascular Dementia- Patient Pool Analysis, Market Size and Market Forecast APAC, 2034" report comprises of detailed understanding of the Vascular Dementia, historical and forecasted patient burden, treatment addressable patient population, as well as key differences in market trends in the APAC region (India, China, South Korea, Taiwan, and Australia) when compared with established markets.
The APAC Vascular Dementia market report provides current treatment pattern analysis, potential upcoming players, market share…
Frontotemporal Dementia APAC Market Poised for Phenomenal Expansion Across APAC …
"DelveInsight's "Frontotemporal Dementia- Patient Pool Analysis, Market Size and Market Forecast APAC, 2034" report comprises of detailed understanding of the Frontotemporal Dementia, historical and forecasted patient burden, treatment addressable patient population, as well as key differences in market trends in the APAC region (India, China, South Korea, Taiwan, and Australia) when compared with established markets.
The APAC Frontotemporal Dementia market report provides current treatment pattern analysis, potential upcoming players, market share…
